Aligos Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ALGS, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
8
Funds holding
$546965
Total value held
Buying
4 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Ubs Group Ag | $346119 | 59986 | +59986 | NEW BUY |
| 2 | Blackrock, Inc. | $174785 | 30292 | +17252 | +132.30% |
| 3 | Royal Bank Of Canada | $12000 | 2125 | — | Held |
| 4 | Citigroup Inc | $10432 | 1808 | +1807 | +180700.00% |
| 5 | Jpmorgan Chase & Co | $1868 | 344 | -330 | -48.96% |
| 6 | Morgan Stanley | $1177 | 204 | -14 | -6.42% |
| 7 | Wells Fargo & Company/Mn | $577 | 100 | -600 | -85.71% |
| 8 | Amalgamated Financial Corp. | $7 | 3439 | +3439 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.